A randomized trial of hydroxyapatite-coated femoral stems in total hip arthroplasty: a 13-year follow-up.
A prospective randomized trial comparing hydroxyapatite (HA)-coated and non-HA-coated femoral total hip arthroplasty components was conducted. Sixty-one consecutive patients undergoing primary hip arthroplasty were randomized to receive an identical femoral component with or without HA. Forty-eight hips were available for review at an average of 13 years and 5 months after surgery. The only femoral stem revised was secondary to femoral fracture after mitral valve area. All femoral stems were well fixed on x-ray with no evidence of loosening. There was no statistically significant difference in the revision rates or in the Harris hip score between the HA vs non-HA-coated groups. This study suggests there is no clinical advantage to the use of a hydroxyapatite coating on the femoral component of this design for primary total hip arthroplasty.
Camazzola
Dan
D
Division of Orthopedic Surgery, York Central Hospital, ON, Canada.
Hammond
Terry
T
Gandhi
Rajiv
R
Davey
J Roderick
JR
D000328:Adult; D019644:Arthroplasty, Replacement, Hip / Q000295:instrumentation* / Q000379:methods; D017886:Durapatite; D005260:Female; D005269:Femur / Q000000981:diagnostic imaging; D005500:Follow-Up Studies; D006622:Hip Prosthesis; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011859:Radiography; D012086:Reoperation; D016896:Treatment Outcome
D017886:Durapatite